Kuhusu ALLOZYNE INC
Allozyne was a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation. Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current standard of care dosed anywhere from once daily to once per week.
Source: Wikipedia
SektaBiotechnology
Makao makuuSeattle, WA
Ilianzishwa2005
Muundo wa kisheriaC Corporation
HaliAmilifu
Mapitio
Bado hakuna mapitio. Umefanya kazi na ALLOZYNE INC? Kuwa wa kwanza kushiriki uzoefu wako.
Takwimu muhimu
Ingia ili kuona takwimu muhimu
Mapato, faida halisi na idadi ya wafanyakazi wa ALLOZYNE INC kwa miaka yote, pamoja na vyanzo vyake.
Ingia Fungua akaunti kwa barua pepe yakoNi bure
Kwa kuendelea, unakubali Makubaliano ya Mtumiaji, Sera ya Faragha na Sera ya Vidakuzi ya Heelky.
Taarifa za kisheria
| Jina la kisheria | ALLOZYNE INC |
|---|---|
| Muundo wa kisheria | C Corporation |
| SEC CIK | 1345630Tazama kwenye SEC EDGAR ↗ |
| Anwani iliyosajiliwa | Seattle, WA |
| Hali | Amilifu |
Vyanzo: SEC EDGAR · imesasishwa Nov. 14, 2026
Mawasiliano na viungo
Mahali
Seattle, WA
Je, hii ni kampuni yako?
Dai ukurasa huu bure kuongeza nembo, bidhaa, picha na kazi zako, na kujibu mapitio.
Dai ukurasa huuJiunge na Heelky kuunganisha, kuajiri na kukua
Unda akaunti ya bure kutuma ujumbe kwa watu, kuomba kazi na kuchapisha misheni.
Jiunge sasa — ni bure